Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eisai is set to introduce Warfarin Granules 0.2%, a new formulation of oral anti-coagulant Warfarin (warfarin potassium), on 1 December in Japan.
Subscribe to our email newsletter
Warfarin is an oral anticoagulant agent largely recommended for treatment and prevention of thromboembolism such as cardiogenic brain embolism and venous thrombosis.
The new formulation is believed to help patients who will have difficulty in swallowing tablets , besides providing healthcare professionals with the ability to easily micro-adjust the dosage of the medication as per patient’s needs.
Warfarin Granules 0.2% allows the ingredient warfarin potassium to be precisely adjusted to less than 0.5 mg, and has been triturated 500-fold to ensure appropriate dose-volume.